Isotype selection in antibody engineering
- 1 December 2007
- journal article
- review article
- Published by Springer Nature in Nature Biotechnology
- Vol. 25 (12) , 1369-1372
- https://doi.org/10.1038/nbt1207-1369
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antibody therapeutics:Expert Opinion on Biological Therapy, 2007
- The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategiesPublished by Elsevier ,2007
- Human Immunoglobulin G2 (IgG2) and IgG4, but Not IgG1 or IgG3, Protect Mice againstCryptococcus neoformansInfectionInfection and Immunity, 2007
- Potent antibody therapeutics by designNature Reviews Immunology, 2006
- Development and regulation of monoclonal antibody products: Challenges and opportunitiesCancer and Metastasis Reviews, 2005
- Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromesVox Sanguinis, 2003
- IgG4 breaking the rulesImmunology, 2002
- Normal human immunoglobulin G4 is bispecific: it has two different antigen‐combining sitesImmunology, 1999
- Localization of the binding site for the human high-affinity Fc receptor on IgGNature, 1988
- Review of the notation for the allotypic and related markers of human immunoglobulinsEuropean Journal of Immunology, 1976